Imexpharm

Imexpharm EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Imexpharm (IMP.VN) as of Oct 26, 2026 is 155.74. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 38.43 — a change of 305.31% (higher).

EV/OCF

155.74

YoY

305.31%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Imexpharm is 2025 155.74 . EV/OCF (Enterprise Value to Operating Cash Flow) of Imexpharm was 2024 38.43 . It decreases by 305.31% higher compared to the previous year.

The Imexpharm EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
60.79 VND
Jan 1, 2019
124.07 VND
Jan 1, 2020
114.21 VND
Jan 1, 2021
36.14 VND
Jan 1, 2022
21.97 VND
Jan 1, 2023
-204.43 VND
Jan 1, 2024
38.43 VND
Jan 1, 2025
155.74 VND
The Imexpharm EV/OCF history
YEAREV/OCFYoY
155.74+305.31%
38.43-118.80%
-204.43-1,030.37%
21.97-39.20%
36.14-68.36%
114.21-7.94%
124.07+104.11%
60.79-25.53%
81.62-14.79%
95.79-46.58%
179.30-65.21%
515.39—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Imexpharm is 155.74 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Imexpharm changed from 38.43 to 155.74, representing a 305.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Imexpharm since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Imexpharm with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Imexpharm

All Key Metrics — Imexpharm